| 1 |
23581564 | Monoamine oxidase B prompts mitochondrial and cardiac dysfunction in pressure overloaded hearts. | 2014 Jan 10 |
1 |
| 2 |
23258538 | Metabolism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by mitochondrion-targeted cytochrome P450 2D6: implications in Parkinson disease. | 2013 Feb 8 |
1 |
| 3 |
10548268 | Reduction of oral ethanol self-administration in rats by monoamine oxidase inhibitors. | 1999 Nov |
1 |
| 4 |
9754903 | Microglial and astrocytic involvement in a murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). | 1998 Jun |
1 |
| 5 |
8469402 | MPTP neurotoxicity to cerebellar Purkinje cells in mice. | 1993 Feb 5 |
1 |
| 6 |
2501477 | Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain. | 1989 Jul |
1 |
| 7 |
2571685 | The neurotoxicity of 1-methyl-4-phenylpyridinium in cultured cerebellar granule cells. | 1989 Oct |
1 |
| 8 |
3121972 | Different effects of monoamine oxidase inhibition on MPTP depletion of heart and brain catecholamines in mice. | 1988 |
4 |
| 9 |
3487620 | The effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on presynaptic dopamine uptake sites in the mouse striatum. | 1986 Jun |
1 |
| 10 |
3945167 | MD 240928 and harmaline: opposite selectivity in antagonism of the inactivation of types A and B monoamine oxidase by pargyline in mice. | 1986 Feb 3 |
2 |
| 11 |
6332989 | Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors. | 1984 Oct 4-10 |
1 |